SAR 20.8
(-0.1%)
Breakdown | 2023 | 2022 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 819.74 Million | 1.16 Billion | 1.47 Billion | 1.03 Billion | 1.16 Billion | 497.32 Million |
Net Income | 1.51 Billion | 1.1 Billion | 473.61 Million | 473.07 Million | 662.89 Million | 748.82 Million |
Depreciation & Amortization | 16.77 Million | 25.35 Million | 563.03 Million | 548.56 Million | 476.83 Million | 292.32 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -82.4 Million | -195.09 Million | 55.33 Million | -324.36 Million | -559.67 Million | -1.02 Billion |
Other non-cash items | -470.06 Million | 222.53 Million | 382.35 Million | 336.74 Million | 589.21 Million | 482.08 Million |
Investing Cash Flow | -681.11 Million | -448.8 Million | -1.07 Billion | -342.82 Million | -463.72 Million | -699.09 Million |
Investments in PPE | -10.01 Million | -1.1 Million | -16.68 Million | -15.56 Million | -7.48 Million | -13.45 Million |
Acquisitions | - | - | -78.82 Million | 97.5 Million | - | - |
Investment purchases | -1.02 Billion | - | - | -235.19 Million | - | - |
Sales/Maturities of investments | 671.91 Million | - | - | 152.65 Million | - | - |
Other Investing Activities | -681.11 Million | -447.69 Million | -981.57 Million | -342.21 Million | -456.23 Million | -685.64 Million |
Financing Cash Flow | -664.08 Million | -640.78 Million | -476.81 Million | -1.1 Billion | -117.52 Million | 579.09 Million |
Debt repayment | -562.48 Million | - | -2.65 Billion | -45 Million | 28.73 Million | -6.22 Billion |
Dividends payments | -1.06 Billion | -474.99 Million | -712.5 Million | -475 Million | -427.5 Million | - |
Common Stock Repurchased | -393.7 Million | - | - | - | - | - |
Common Stock Issuance | 390.75 Million | - | - | - | - | - |
Other Financing Activities | -342.86 Million | -165.78 Million | 2.89 Billion | -581.21 Million | 281.23 Million | 6.8 Billion |
Accounts receivables | -389.47 Million | -195.09 Million | - | -494.87 Million | -132.89 Million | -50.89 Million |
Accounts payables | 263.47 Million | - | - | - | - | - |
Inventory | -7.84 Million | - | - | - | - | - |
Other working capital | 43.58 Million | - | - | 170.51 Million | -426.77 Million | -975 Million |
Cash at beginning of period | 132.6 Million | 635.66 Million | 635.66 Million | 1.04 Billion | 457.67 Million | 80.35 Million |
Cash at end of period | 2.91 Million | 556.12 Million | 556.12 Million | 635.66 Million | 1.04 Billion | 457.67 Million |
Capital Expenditure | -10.01 Million | -1.1 Million | -16.68 Million | -15.56 Million | -7.48 Million | -13.45 Million |
Effect of forex changes on cash | - | -151.96 Million | - | 1.00 | -1.00 | - |
Net cash flow / Change in cash | -129.68 Million | -79.54 Million | -79.54 Million | -410.01 Million | 588 Million | 377.32 Million |
Free Cash Flow | 809.73 Million | 1.16 Billion | 1.45 Billion | 1.01 Billion | 1.16 Billion | 483.87 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 353.11 Million | 178.33 Million | 1.51 Billion | 506.45 Million | 286.54 Million | 338.65 Million |
Depreciation & Amortization | 4.51 Million | 3.64 Million | 16.77 Million | 3.59 Million | 4.23 Million | 4.75 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -275.96 Million | -476.59 Million | -82.4 Million | -21.04 Million | -97.15 Million | 30.59 Million |
Other non-cash items | 56.08 Million | 550.26 Million | -470.06 Million | -340.98 Million | 116.11 Million | 17.09 Million |
Investing Cash Flow | -494.34 Million | -149.66 Million | -681.11 Million | -462.67 Million | -117.09 Million | -105.2 Million |
Investments in PPE | -2.62 Million | -4.1 Million | -10.01 Million | -2.89 Million | -666.55 Thousand | -6.45 Million |
Acquisitions | -3.83 Million | - | - | - | - | - |
Investment purchases | -491.72 Million | -145.56 Million | -1.02 Billion | -156.98 Million | -116.42 Million | - |
Sales/Maturities of investments | - | - | 671.91 Million | 26.6 Million | - | - |
Other Investing Activities | -494.34 Million | -149.66 Million | -681.11 Million | -7.12 Million | -117.09 Million | -98.75 Million |
Financing Cash Flow | 252.25 Million | 771.63 Million | -664.08 Million | 43.34 Million | -288.47 Million | -504.33 Million |
Debt repayment | -696.32 Million | -814.87 Million | -562.48 Million | -44.73 Million | -131.71 Million | - |
Dividends payments | -356.25 Million | - | -1.06 Billion | - | -367.1 Million | -341 Million |
Common Stock Repurchased | -277.29 Million | -310.04 Million | -393.7 Million | -391 Million | -2.69 Million | - |
Common Stock Issuance | 276.55 Million | 310.79 Million | 390.75 Million | 390.75 Million | - | - |
Other Financing Activities | 152.58 Million | 696.65 Million | -342.86 Million | -2.11 Million | -62.69 Million | -163.33 Million |
Accounts receivables | -83.21 Million | -305.99 Million | -389.47 Million | -142.53 Million | -169.55 Million | 30.59 Million |
Accounts payables | -50.82 Million | -71.73 Million | 263.47 Million | 90.25 Million | 69.05 Million | - |
Inventory | - | - | -7.84 Million | -7.84 Million | - | - |
Other working capital | -141.91 Million | -98.86 Million | 43.58 Million | 31.22 Million | 3.34 Million | - |
Cash at beginning of period | 919.99 Thousand | 2.91 Million | 132.6 Million | 3.29 Million | 82.18 Million | 839.02 Million |
Cash at end of period | 960 Thousand | 919.99 Thousand | 2.91 Million | 2.91 Million | 3.29 Million | 620.57 Million |
Capital Expenditure | -2.62 Million | -4.1 Million | -10.01 Million | -2.89 Million | -666.55 Thousand | -6.45 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 40 Thousand | -1.99 Million | -129.68 Million | -373.58 Thousand | -78.88 Million | -218.44 Million |
Free Cash Flow | -7.94 Million | -133.46 Million | 809.73 Million | 85.65 Million | 200.1 Million | 384.64 Million |
3540
1449
3RG
INFN
MTAGF
WHA